参考文献/References:
[1]FAN J,WATANABE T.Atherosclerosis:Known and unknown[J].Pathol Int,2022,72(3):151-160.
[2]刘宁,艾英,刘健.芦黄颗粒联合单硝酸异山梨酯治疗冠心病不稳定型心绞痛疗效及对患者心功能与脂代谢的影响[J].陕西中医,2023,44(1):64-67.
[3]CHEN Z,OUYANG C,ZHANG H,et al.Vascular smooth muscle cell-derived hydrogen sulfide promotes atherosclerotic plaque stability via TFEB (transcription factor EB)-mediated autophagy[J].Autophagy,2022,18(10):2270-2287.
[4]PI S,MAO L,CHEN J,et al.The P2RY12 receptor promotes VSMC-derived foam cell formation by inhibiting autophagy in advanced atherosclerosis[J].Autophagy,2021,17(4):980-1000.
[5]TAKANO M,HIROSE N,SUMI C,et al.ANGPTL2 promotes inflammation via integrin α5β1 in chondrocytes[J].Cartilage,2021,13(2):885s-897s.
[6]LABBE P,MUNOZ GOYETTE V,THORIN-TRESCASES N,et al.Angiopoietin-like 2 is essential to aortic valve development in mice[J].Commun Biol,2022,5(1):1277.
[7]YANG H,LIU J,CHEN X,et al.Angptl2 gene knockdown is critical for abolishing angiotensin Ⅱ-induced vascular smooth muscle cell proliferation and migration[J].Biochem Cell Biol,2022,100(1):59-67.
[8]CHEN W,WANG J,WANG X,et al.Knockdown of hypoxia-inducible factor 1-alpha (HIF1α) interferes with angiopoietin-like protein 2 (ANGPTL2) to attenuate high glucose-triggered hypoxia/reoxygenation injury in cardiomyocytes[J].Bioengineered,2022,13(1):1476-1490.
[9]王伊凡,李思远,张姣.右美托咪定预处理通过PI3K/Akt/mTOR信号通路对心肌缺血再灌注大鼠心脏损伤和心肌组织自噬的影响[J].陕西医学杂志,2023,52(10):1299-1303.
[10]LI R,ZHENG Y,ZHANG J,et al.Gomisin N attenuated cerebral ischemia-reperfusion injury through inhibition of autophagy by activating the PI3K/AKT/mTOR pathway[J].Phytomedicine,2023,110:154644.
[11]TANG H Y,CHEN A Q,ZHANG H,et al.Vascular Smooth muscle cells phenotypic switching in cardiovascular diseases[J].Cells,2022,11(24):4060.
[12]WORSSAM M D,JORGENSEN H F.Mechanisms of vascular smooth muscle cell investment and phenotypic diversification in vascular diseases[J].Biochem Soc Trans,2021,49(5):2101-2111.
[13]ZHU Y,TIAN X,WANG Y,et al.Inhibition of lncRNA NFIA-AS1 alleviates abnormal proliferation and inflammation of vascular smooth muscle cells in atherosclerosis by regulating miR-125a-3p/AKT1 axis[J].Int J Genomics,2023,2023:8437898.
[14]LIN H H,HSIEH M C,WANG C P,et al.Anti-atherosclerotic effect of gossypetin on abnormal vascular smooth muscle cell proliferation and migration[J].Antioxidants (Basel),2021,10(9):1357.
[15]李霞,王景梅,李军华,等.血清miR-124、CD146及Angptl2水平与急性脑梗死患者颈动脉粥样硬化斑块稳定性的关系研究[J].国际检验医学杂志,2024,45(17):2121-2126,2131.
[16]HANG J.Biomarkers of endothelial activation and dysfunction in cardiovascular diseases[J].Rev Cardiovasc Med,2022,23(2):73.
[17]LABBE P,MARTEL C,SHI Y F,et al.Knockdown of ANGPTL2 promotes left ventricular systolic dysfunction by upregulation of NOX4 in mice[J].Front Physiol,2024,15:1320065.
[18]杜华,李杰.冠心病患者血清中MMP-9、Angptl2、炎症因子与患者CT下斑块性质及预后的关系[J].实验与检验医学,2023,41(2):136-138,152.
[19]ZROBICHAUD S,RASHEED A,PIETRANGELO A,et al.Autophagy is differentially regulated in leukocyte and nonleukocyte foam cells during atherosclerosis[J].Circ Res,2022,130(6):831-847.
[20]LU Q,YAO Y,HU Z,et al.Angiogenic factor Aggf1 activates autophagy with an essential role in therapeutic angiogenesis for heart disease[J].PLoS Biol,2016,14(8):e1002529.
[21]TANG Z L,ZHANG K,LV S C,et al.LncRNA MEG3 suppresses PI3K/AKT/mTOR signalling pathway to enhance autophagy and inhibit inflammation in TNF-α treated keratinocytes and psoriatic mice[J].Cytokine,2021,148:155657.
[22]LIU C,CHEN G,CHEN Y,et al.Danlou tablets inhibit atherosclerosis in apolipoprotein E-Deficient mice by inducing macrophage autophagy:The role of the PI3K-Akt-mTOR pathway[J].Front Pharmacol,2021,12:724670.
[23]LI F,PENG J,LU Y,et al.Blockade of CXCR4 promotes macrophage autophagy through the PI3K/AKT/mTOR pathway to alleviate coronary heart disease[J].Int J Cardiol,2023,392:131303.
相似文献/References:
[1]李艳艳,贾 伟△.24h动态心电图在2型糖尿病合并冠心病患者心律诊断中的价值分析[J].陕西医学杂志,2019,(1):61.
[2]汤克虎,高峻峰,任尽平.药物涂层球囊在糖尿病患者冠状动脉小血管病变治疗中的应用研究*[J].陕西医学杂志,2019,(4):432.
[3]马党捐 ,康彦智 ,柴茂林.64排128层螺旋CT冠状动脉成像在冠心病患者诊断中的价值研究*[J].陕西医学杂志,2019,(5):624.
MA Dangjuan,KANG Yanzhi,CHAI Maolin..Value analysis of 64rows 128slice spiral CT coronary angiography in the diagnosis of patients with coronary heart disease[J].,2019,(7):624.
[4]沈 琳,马文苑.曲美他嗪联合氯吡格雷治疗冠心病心绞痛疗效及对患者心电图、血清超敏C反应蛋白和五聚素3的影响[J].陕西医学杂志,2019,(6):794.
SHEN Lin,MA Wenyuan.ElectrocardiogramRoom,Therapeutic Effect ofTrimetazidine Combined with Clopidogrel on Angina Pectoris and its Hs-CRP[J].,2019,(7):794.
[5]杨延洁,周慧龙△.不同双抗血小板疗程对冠心病合并房颤PCI术后患者远期预后的影响*[J].陕西医学杂志,2019,(12):1653.
[6]魏 勇,梁 琪,左浩源,等.右美托咪定预处理对冠心病非心脏手术患者心肌的保护作用*[J].陕西医学杂志,2019,(12):1706.
WEI Yong,LIANG Qi,ZUO Haoyuan,et al.Protective effect of dexmedetomidine preconditioning on myocardium in patients with coronary heart disease undergoing nonheart surgery[J].,2019,(7):1706.
[7]刘玉珊.心外膜脂肪定量及可溶性血栓调节蛋白与冠心病病变程度相关性分析[J].陕西医学杂志,2020,49(1):44.
LIU Yushan..Correlation between the distribution of epicardial adipose tissue and soluble thrombomodulin and the severity of coronary heart disease[J].,2020,49(7):44.
[8]赵 博,王银谦,王红燕.巨噬细胞移动抑制因子与冠心病关系Meta分析[J].陕西医学杂志,2020,49(1):125.
[9]王亚平,彭春艳,朱名安Δ.冠心病合并代谢综合征患者固醇调节元件结合蛋白表达水平与脂代谢指标相关性研究*[J].陕西医学杂志,2020,49(4):419.
WANG Yaping,PENG Chunyan,ZHU Mingan..Correlation between the levels of SREBPs and the indicators of lipid metabolism in patients with coronary heart disease complicated with metabolic syndrome[J].,2020,49(7):419.
[10]南格利.冠心病颈动脉超声参数与斑块稳定性及炎症反应水平相关性分析[J].陕西医学杂志,2020,49(4):453.
NAN Geli..Correlation between carotid ultrasound parameters and plaque stability and inflammatory response in patients with coronary heart disease[J].,2020,49(7):453.